Galapagos NV
GLPG
#4539
Rank
โ‚ฌ1.88 B
Marketcap
28,54ย โ‚ฌ
Share price
-0.73%
Change (1 day)
28.17%
Change (1 year)

Market capitalization of Galapagos NV (GLPG)

Market cap: โ‚ฌ1.88 Billion

As of February 2026 Galapagos NV has a market cap of โ‚ฌ1.88 Billion. This makes Galapagos NV the world's 4539th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Galapagos NV from 2008 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ1.88 B1.51%
2025โ‚ฌ1.85 B7.18%
2024โ‚ฌ1.72 B-28.66%
2023โ‚ฌ2.42 B-11.04%
2022โ‚ฌ2.72 B-15.56%
2021โ‚ฌ3.22 B-38.72%
2020โ‚ฌ5.26 B-56.35%
2019โ‚ฌ12.05 B174.87%
2018โ‚ฌ4.38 B9.61%
2017โ‚ฌ4.00 B41.28%
2016โ‚ฌ2.83 B25.66%
2015โ‚ฌ2.25 B380.44%
2014โ‚ฌ0.46 B3.4%
2013โ‚ฌ0.45 B6.23%
2012โ‚ฌ0.42 B55.55%
2011โ‚ฌ0.27 B-14.13%
2010โ‚ฌ0.31 B79.77%
2009โ‚ฌ0.17 B142.03%
2008โ‚ฌ73.5 M

End of Day market cap according to different sources

On Feb 1st, 2026 the market cap of Galapagos NV was reported to be:

โ‚ฌ1.88 Billion
by Nasdaq info icon info icon
โ‚ฌ1.88 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ461.22 B 24,423.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ160.25 B 8,420.68%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ332.02 B 17,554.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ96.24 B 5,017.59%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚ฌ232.02 B 12,236.80%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ242.30 B 12,783.66%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚ฌ87.85 B 4,571.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
โ‚ฌ81.05 M-95.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ32.93 B 1,651.30%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel